Risk-Based Post-Marketing Surveillance (RB-PMS) of antimalarial drugs and maternal, neonatal and reproductive health (MNCH) in Mali
Abstract
Objectives: In a world marked by the increase in chemoresistance leading to the adoption of therapeutic combinations, the advent of generic multi-source drugs, the spread of counterfeiting and substandard drugs, often without active ingredients or falsified active ingredients, a Greater vigilance by pharmaceutical regulatory authorities is needed. Drug Post-Marketing Surveillance (PMS) therefore plays an important role in detecting poor quality products on the market. Risk-Based Post-Marketing Surveillance (RB-PMS) is a new form of PMS that is emerging and was the subject of a recent WHO publication.
Methods: The survey covered certain regions and certain points of sale identified by a Technical Working Group. It aimed to assess the quality of antimalarial and MNCRH drugs available at certain risk distribution levels based on priority sites. The selection of drugs and geographic areas was made using risk-based sampling using the Drug Risk Assessment Tool (MedRS) developed by USP / PQM +.
Results: A total of 242 samples were taken and analyzed according to a risk-based protocol, of which 233 were compliant with a rate of 96% against 9 were non-compliant or 4% (P≤0,05). Non-compliant drugs were mainly from the public sector. We found 69% of the unregistered drugs that consisted mainly of antimalarial drugs and which came from India and China.
Conclusion: In view of the scarcity of resources and its scientific nature, this risk-based sampling and analysis technique (RB-PMS) must be pursued, optimized and made sustainable to ensure health and guarantee access to quality medicines for the health and well-being of populations.
Keywords: Antimalarials, MNCH, Quality Control, RB-PMS.
Keywords:
Antimalarials, MNCH, Quality Control, RB-PMSDOI
https://doi.org/10.22270/jddt.v12i2.5223References
World malaria report 2019 [Internet]. [cité 30 déc 2021]. Disponible sur: https://www.who.int/publications-detail-redirect/9789241565721
Mali [Internet]. Severe Malaria Observatory. [cité 30 déc 2021]. Disponible sur: https://www.severemalaria.org/fr/pays/mali
Demographic and Health Survey in Mali 2018.pdf
WHO | WHO Global Surveillance and Monitoring System [Internet]. WHO. [cité 27 nov 2020]. Disponible sur: http://www.who.int/medicines/regulation/ssffc/surveillance/en/
Handbook_of_training_materials_SF_French.pdf [Internet]. [cité 30 déc 2021]. Disponible sur: https://www.who.int/medicines/regulation/ssffc/mechanism/Handbook_of_training_materials_SF_French.pdf
Pitts A. Guidance for Implementing Risk-based Post-marketing Quality Surveillance in Low- and Middle-income Countries. :54.
MedRS | Log In [Internet]. [cité 29 déc 2021]. Disponible sur: https://medrsv2.com/
Drug Quality Promotion Program. Strengthening National Capacity in Medicine Quality: Five-Year Summary (2005-2009) of the Medicine Quality Promotion Program in Southeast Asia and the Philippines. Rockville, Md: The United States Pharmacopoeial Convention. Accessed: 09 Nov. 2018. Available at: http://www.usp-pqm.org/sites/default/files/pqms/article/rdmareport.pdf
A Sidibé O. Quality control of medicines antimalarials in seven (07) administratives regions of mali and Bamako district: operationalization of minilab kits. Published online 2012. Accessed December 23, 2021. https://www.bibliosante.ml/handle/123456789/1856
Published
Abstract Display: 565 
PDF Downloads: 347 PDF Downloads: 52 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.